vs
Acadia Healthcare Company, Inc.（ACHC）とSimpson Manufacturing Co., Inc.（SSD）の財務データ比較。上の社名をクリックして会社を切り替えられます
Acadia Healthcare Company, Inc.の直近四半期売上が大きい（$829.0M vs $588.0M、Simpson Manufacturing Co., Inc.の約1.4倍）。Simpson Manufacturing Co., Inc.の純利益率が高く（15.0% vs 0.5%、差は14.5%）。Simpson Manufacturing Co., Inc.の前年同期比売上増加率が高い（9.1% vs 7.5%）。過去8四半期でAcadia Healthcare Company, Inc.の売上複合成長率が高い（2.0% vs -0.8%）
アカディア・ヘルスケアはアメリカ合衆国に本拠を置く営利目的の行動医療サービス提供企業です。現在アメリカ本土とプエルトリコにわたり225カ所以上の医療施設を運営し、広範な行動ヘルスケアネットワークを構築して、専門的なサービスを提供しています。
シンプソン・マニュファクチャリングは米国屈指の建築資材メーカーで、新築工事や改修工事向けの構造用接合金物、ファスナー、アンカーなどの製品を製造・供給しており、業界で高い技術力と市場シェアを誇っています。
ACHC vs SSD — 直接比較
損益計算書 — Q1 FY2026 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $829.0M | $588.0M |
| 純利益 | $4.5M | $88.2M |
| 粗利率 | — | 45.2% |
| 営業利益率 | — | 19.5% |
| 純利益率 | 0.5% | 15.0% |
| 売上前年比 | 7.5% | 9.1% |
| 純利益前年比 | -50.8% | 13.3% |
| EPS（希薄化後） | $0.05 | $2.13 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $829.0M | $588.0M | ||
| Q4 25 | $821.5M | $539.3M | ||
| Q3 25 | $851.6M | $623.5M | ||
| Q2 25 | $869.2M | $631.1M | ||
| Q1 25 | $770.5M | $538.9M | ||
| Q4 24 | $774.2M | $517.4M | ||
| Q3 24 | $815.6M | $587.2M | ||
| Q2 24 | $796.0M | $597.0M |
| Q1 26 | $4.5M | $88.2M | ||
| Q4 25 | $-1.2B | $56.2M | ||
| Q3 25 | $36.2M | $107.4M | ||
| Q2 25 | $30.1M | $103.5M | ||
| Q1 25 | $8.4M | $77.9M | ||
| Q4 24 | $32.6M | $55.4M | ||
| Q3 24 | $68.1M | $93.5M | ||
| Q2 24 | $78.5M | $97.8M |
| Q1 26 | — | 45.2% | ||
| Q4 25 | — | 43.4% | ||
| Q3 25 | — | 46.4% | ||
| Q2 25 | — | 46.7% | ||
| Q1 25 | — | 46.8% | ||
| Q4 24 | — | 44.0% | ||
| Q3 24 | — | 46.8% | ||
| Q2 24 | — | 46.7% |
| Q1 26 | — | 19.5% | ||
| Q4 25 | -142.4% | 13.9% | ||
| Q3 25 | 4.7% | 22.6% | ||
| Q2 25 | 5.8% | 22.2% | ||
| Q1 25 | 1.7% | 19.0% | ||
| Q4 24 | 4.9% | 14.8% | ||
| Q3 24 | 12.1% | 21.3% | ||
| Q2 24 | 13.4% | 22.1% |
| Q1 26 | 0.5% | 15.0% | ||
| Q4 25 | -143.3% | 10.4% | ||
| Q3 25 | 4.3% | 17.2% | ||
| Q2 25 | 3.5% | 16.4% | ||
| Q1 25 | 1.1% | 14.5% | ||
| Q4 24 | 4.2% | 10.7% | ||
| Q3 24 | 8.4% | 15.9% | ||
| Q2 24 | 9.9% | 16.4% |
| Q1 26 | $0.05 | $2.13 | ||
| Q4 25 | $-12.98 | $1.34 | ||
| Q3 25 | $0.40 | $2.58 | ||
| Q2 25 | $0.33 | $2.47 | ||
| Q1 25 | $0.09 | $1.85 | ||
| Q4 24 | $0.36 | $1.31 | ||
| Q3 24 | $0.74 | $2.21 | ||
| Q2 24 | $0.85 | $2.31 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $158.5M | $341.0M |
| 総負債低いほど良い | $2.5B | — |
| 株主資本純資産 | $2.0B | $2.1B |
| 総資産 | $5.5B | $3.0B |
| 負債/資本比率低いほどレバレッジが低い | 1.29× | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $158.5M | $341.0M | ||
| Q4 25 | $133.2M | $384.1M | ||
| Q3 25 | $118.7M | $297.3M | ||
| Q2 25 | $131.4M | $190.4M | ||
| Q1 25 | $91.2M | $150.3M | ||
| Q4 24 | $76.3M | $239.4M | ||
| Q3 24 | $82.1M | $339.4M | ||
| Q2 24 | $77.2M | $354.9M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $300.0M | ||
| Q3 25 | $2.3B | $371.3M | ||
| Q2 25 | $2.3B | $376.9M | ||
| Q1 25 | $2.2B | $382.5M | ||
| Q4 24 | $2.0B | $388.1M | ||
| Q3 24 | $1.9B | $393.8M | ||
| Q2 24 | $1.8B | $399.4M |
| Q1 26 | $2.0B | $2.1B | ||
| Q4 25 | $1.9B | $2.0B | ||
| Q3 25 | $3.1B | $2.0B | ||
| Q2 25 | $3.1B | $1.9B | ||
| Q1 25 | $3.0B | $1.9B | ||
| Q4 24 | $3.1B | $1.8B | ||
| Q3 24 | $3.0B | $1.9B | ||
| Q2 24 | $3.0B | $1.8B |
| Q1 26 | $5.5B | $3.0B | ||
| Q4 25 | $5.5B | $3.1B | ||
| Q3 25 | $6.4B | $3.0B | ||
| Q2 25 | $6.3B | $3.0B | ||
| Q1 25 | $6.1B | $2.8B | ||
| Q4 24 | $6.0B | $2.7B | ||
| Q3 24 | $5.9B | $2.9B | ||
| Q2 24 | $5.7B | $2.8B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.15× | ||
| Q3 25 | 0.74× | 0.19× | ||
| Q2 25 | 0.74× | 0.20× | ||
| Q1 25 | 0.72× | 0.21× | ||
| Q4 24 | 0.64× | 0.21× | ||
| Q3 24 | 0.62× | 0.21× | ||
| Q2 24 | 0.62× | 0.23× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $61.5M | — |
| フリーキャッシュフロー営業CF - 設備投資 | — | — |
| FCFマージンFCF / 売上 | — | — |
| 設備投資強度設備投資 / 売上 | — | — |
| キャッシュ転換率営業CF / 純利益 | 13.78× | — |
| 直近12ヶ月FCF直近4四半期 | — | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $155.7M | ||
| Q3 25 | $73.2M | $170.2M | ||
| Q2 25 | $133.5M | $125.2M | ||
| Q1 25 | $11.5M | $7.6M | ||
| Q4 24 | $116.7M | $115.8M | ||
| Q3 24 | $163.1M | $103.3M | ||
| Q2 24 | $171.1M | $111.1M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $119.0M | ||
| Q3 25 | $-63.0M | $133.9M | ||
| Q2 25 | $-34.2M | $87.3M | ||
| Q1 25 | $-163.2M | $-42.6M | ||
| Q4 24 | $-86.8M | $60.3M | ||
| Q3 24 | $-27.1M | $58.1M | ||
| Q2 24 | $16.9M | $70.9M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 22.1% | ||
| Q3 25 | -7.4% | 21.5% | ||
| Q2 25 | -3.9% | 13.8% | ||
| Q1 25 | -21.2% | -7.9% | ||
| Q4 24 | -11.2% | 11.7% | ||
| Q3 24 | -3.3% | 9.9% | ||
| Q2 24 | 2.1% | 11.9% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 6.8% | ||
| Q3 25 | 16.0% | 5.8% | ||
| Q2 25 | 19.3% | 6.0% | ||
| Q1 25 | 22.7% | 9.3% | ||
| Q4 24 | 26.3% | 10.7% | ||
| Q3 24 | 23.3% | 7.7% | ||
| Q2 24 | 19.4% | 6.7% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 2.77× | ||
| Q3 25 | 2.02× | 1.58× | ||
| Q2 25 | 4.43× | 1.21× | ||
| Q1 25 | 1.37× | 0.10× | ||
| Q4 24 | 3.58× | 2.09× | ||
| Q3 24 | 2.39× | 1.10× | ||
| Q2 24 | 2.18× | 1.14× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
SSD
セグメントデータなし
